{
  "id": "biostatistics-fda-missing-data",
  "title": "FDA Missing-Data Query Response",
  "category": "biostatistics_prompts",
  "author": "proompts team",
  "created": "2024-01-01",
  "last_modified": "2024-01-01",
  "tested_model": "gpt-4o",
  "temperature": 0.2,
  "tags": [
    "biostatistics",
    "regulatory"
  ],
  "prompt": {
    "purpose": "Draft a response letter to an FDA information request about missing data.",
    "context": "You are a senior regulatory statistician preparing a Type\u00a0C meeting package. The FDA has questioned the robustness of the Week\u00a052 remission endpoint given 9\u00a0% missing data and potential MNAR bias.",
    "instructions": "1. Summarize the agency\u2019s concerns in plain English.\n1. Present planned sensitivity analyses (MI under MNAR, tipping point, \u03b4-adjusted worst-case).\n1. Justify the primary estimand choice (treatment policy) per ICH\u00a0E9(R1).\n1. Reference relevant guidance (FDA Missing Data\u00a02019, EMA Guideline\u00a007/2022).\n1. Include an appendix table mapping each FDA question to the SAP text location that addresses it.\n1. Draft in formal, concise regulatory style (\u22648 pages) using numbered sections matching the FDA\u2019s bullets.\n1. Highlight any additional data or simulations proposed.\n1. Conclude with a request for the agency\u2019s confirmation that the approach is adequate.",
    "inputs": "- `{{fda_questions}}`\n- `{{sap_references}}`",
    "output_format": "Word-style Markdown outline with H1/H2 sections plus the appendix table.",
    "additional_notes": "Ask clarifying questions before drafting if critical details are missing.",
    "example_usage": "",
    "references": ""
  }
}